How do you pay?
How many tablets?

How to pay the least

Ask for the cash price

Generic clomiphene

Only Costco posts a price for clomiphene 50 mg, 30 tablets, and it’s for members.

What to do

  1. Ask your pharmacy: “What’s your cash price for generic clomiphene 50 mg, 30 tablets?”Find pharmacies near you 
  2. Ask one or two other pharmacies too. Cash prices for the same generic can differ a lot from store to store.

Other ways

With a membership $129.99 for 30 tablets at Costco ($65 a year).

See Costco’s price list 

A regular generic has the same active ingredient as Clomid, and the FDA requires it to work the same way.

See every pharmacy’s price

Compare every option

Brand name

Clomid itself isn’t sold as a prescription anymore.

Not soldNo longer sold

Authorized generic

One was sold before, but not anymore.

Not soldNo longer sold

Regular generic

Same active ingredient as Clomid. Fillers and dyes can differ.

Cash priceMembers only$129.99 for 30 tablets at Costco
Where to buy it and who makes it

Where to buy it

Pharmacies’ own cash prices for generic clomiphene, lowest first.

Pick up in storeDelivered

From each pharmacy’s own site, read November 17, 2026. Confirm the price before you fill.

About these prices

Prices change, can differ by store and state, and may depend on the strength and how many you take. With insurance, ask what your plan charges; it can be less.

Who makes it

6 companies sell a generic of Clomid that the FDA rates a substitute. A pharmacy fills whichever one it stocks. To get a certain maker, ask for it by name; most pharmacies can order it in a day or two.

  • Accord Healthcare50 mg

    Has lactose

    Product page on accordhealthcare.us

    How it looks, what’s in it, NDCs

    50 mg OFF-WHITE, round, 9 mm, marked “OPP / 1068”

    PackageNDC
    Carton of 3016729-723-51

    Inactive ingredients: starch, corn, lactose monohydrate, magnesium stearate, sucrose

    FDA label

  • Advagen Pharma50 mg

    Has lactose · Made by Rubicon Research

    How it looks, what’s in it, NDCs

    50 mg White to off-white, round, 9 mm, marked “UpArrowhead / K5”

    PackageNDC
    Carton of 1072888-213-08
    Carton of 3072888-213-58

    Inactive ingredients: starch, corn, lactose monohydrate, magnesium stearate, sucrose

    FDA label

  • ANI Pharmaceuticals50 mg

    Has lactose · Made by Novitium Pharma

    Product page on anipharmaceuticals.com

    How it looks, what’s in it, NDCs

    50 mg Off white, round, 9 mm, marked “N / 825”

    PackageNDC
    Carton of 1070954-825-20
    Carton of 3070954-825-30

    Inactive ingredients: starch, corn, lactose monohydrate, magnesium stearate, sucrose

    FDA label

  • Burel Pharmaceuticals50 mg

    Has lactose · Sold as MiloPhene · Made by Granata Bio

    How it looks, what’s in it, NDCs

    50 mg OFF-WHITE, round, 9 mm, marked “G50”

    PackageNDC
    Bottle of 1035573-470-75
    Bottle of 3035573-470-30

    Inactive ingredients: starch, corn, lactose monohydrate, magnesium stearate, sucrose

    FDA label

  • Cosette Pharmaceuticals50 mg

    Has lactose · Sold as Clomid

    Product page on cosettepharma.com

    How it looks, what’s in it, NDCs

    50 mg OFF-WHITE, round, 9 mm, marked “Par / 701”

    PackageNDC
    Carton of 100713-0885-09
    Carton of 300713-0885-30

    50 mg OFF-WHITE, round, 9 mm, marked “CL / 22”

    PackageNDC
    Carton of 1083390-107-09
    Carton of 3083390-107-30

    Inactive ingredients: starch, corn, lactose monohydrate, magnesium stearate, sucrose

    FDA label

  • Rising Pharma Holdings50 mg

    Has lactose · Made by Appco Pharma

    How it looks, what’s in it, NDCs

    50 mg White to off-white, round, 9 mm, marked “A / 41”

    PackageNDC
    Bottle of 1064980-690-01
    Carton of 1064980-690-90
    Bottle of 3064980-690-03

    Inactive ingredients: silicon dioxide, lactose monohydrate, magnesium stearate, starch, corn

    FDA label

Who sells it: FDA and Medicaid records, updated weekly. Each maker’s page, card and program is from its own site.

What it’s used for

  • Ovulation problems in women trying to get pregnant
What the FDA label says

Clomiphene citrate is indicated for the treatment of ovulatory dysfunction in women desiring pregnancy. Impediments to achieving pregnancy must be excluded or adequately treated before beginning clomiphene citrate therapy. Those patients most likely to achieve success with clomiphene therapy include patients with polycystic ovary syndrome (see WARNINGS: Ovarian Hyperstimulation Syndrome), amenorrhea-galactorrhea syndrome, psychogenic amenorrhea, post-oral-contraceptive amenorrhea, and certain cases of secondary amenorrhea of undetermined etiology.

Properly timed coitus in relationship to ovulation is important. A basal body temperature graph or other appropriate tests may help the patient and her physician determine if ovulation occurred. Once ovulation has been established, each course of clomiphene citrate should be started on or about the 5th day of the cycle. Long-term cyclic therapy is not recommended beyond a total of about six cycles (including three ovulatory cycles). (See DOSAGE AND ADMINISTRATIONand PRECAUTIONS.)

Clomiphene citrate is indicated only in patients with demonstrated ovulatory dysfunction who meet the conditions described below:

  • Patients who are not pregnant.
  • Patients without ovarian cysts. Clomiphene citrate should not be used in patients with ovarian enlargement except those with polycystic ovary syndrome. Pelvic examination is necessary prior to the first and each subsequent course of clomiphene citrate treatment.
  • Patients without abnormal vaginal bleeding. If abnormal vaginal bleeding is present, the patient should be carefully evaluated to ensure that neoplastic lesions are not present.
  • Patients with normal liver function.

In addition, patients selected for clomiphene citrate therapy should be evaluated in regard to the following:

  • Estrogen Levels.Patients should have adequate levels of endogenous estrogen (as estimated from vaginal smears, endometrial biopsy, assay of urinary estrogen, or from bleeding in response to progesterone). Reduced estrogen levels, while less favorable, do not preclude successful therapy.
  • Primary Pituitary or Ovarian Failure.Clomiphene citrate therapy cannot be expected to substitute for specific treatment of other causes of ovulatory failure.
  • Endometriosis and Endometrial Carcinoma.The incidence of endometriosis and endometrial carcinoma increases with age as does the incidence of ovulatory disorders. Endometrial biopsy should always be performed prior to clomiphene citrate therapy in this population.
  • Other Impediments to Pregnancy.Impediments to pregnancy can include thyroid disorders, adrenal disorders, hyperprolactinemia, and male factor infertility.
  • Uterine Fibroids.Caution should be exercised when using clomiphene citrate in patients with uterine fibroids due to the potential for further enlargement of the fibroids.

There are no adequate or well-controlled studies that demonstrate the effectiveness of clomiphene citrate in the treatment of male infertility. In addition, testicular tumors and gynecomastia have been reported in males using clomiphene. The cause and effect relationship between reports of testicular tumors and the administration of clomiphene citrate is not known.

Although the medical literature suggests various methods, there is no universally accepted standard regimen for combined therapy (i.e., clomiphene citrate in conjunction with other ovulation-inducing drugs). Similarly, there is no standard clomiphene citrate regimen for ovulation induction in vitrofertilization programs to produce ova for fertilization and reintroduction. Therefore, clomiphene citrate is not recommended for these uses.

Source: the FDA label for Clomid (Cosette Pharmaceuticals, Inc.), January 31, 2025. Full label on DailyMed